Recent Analyst Forecasts and Stock Ratings
Pliant Therapeutics, Inc. FAQ's
Pliant Therapeutics, Inc. has been rated by research analysts at Stifel Nicolaus, Leerink Partners, H.C. Wainwright, Piper Sandler, Oppenheimer, RBC Capital in the past 90 days.